- Home
- CCBG vs EYPT Comparison
CCBG vs EYPT Comparison
Compare CCBG & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCBG | EYPT |
|---|---|---|
| Founded | 1895 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.2M | 1.5B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | CCBG | EYPT |
|---|---|---|
| Price | $44.01 | $18.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $45.00 | $29.60 |
| AVG Volume (30 Days) | 65.6K | ★ 1.3M |
| Earning Date | 01-27-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.37% | N/A |
| EPS Growth | ★ 17.47 | N/A |
| EPS | ★ 3.57 | N/A |
| Revenue | ★ $246,433,000.00 | $42,339,000.00 |
| Revenue This Year | $12.46 | N/A |
| Revenue Next Year | $3.24 | N/A |
| P/E Ratio | $12.27 | ★ N/A |
| Revenue Growth | ★ 9.03 | N/A |
| 52 Week Low | $32.38 | $3.91 |
| 52 Week High | $45.63 | $19.11 |
Technical Indicators
Market Signals| Indicator | CCBG | EYPT |
|---|---|---|
| Relative Strength Index (RSI) | 58.22 | 69.43 |
| Support Level | $43.53 | $16.52 |
| Resistance Level | $45.48 | $17.40 |
| Average True Range (ATR) | 0.99 | 1.08 |
| MACD | 0.05 | 0.06 |
| Stochastic Oscillator | 57.46 | 82.58 |
Price Performance
Historical ComparisonAbout CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.